13threephotography/iStock Editorial via Getty Images GSK (NYSE:GSK) said its respiratory syncytial virus (RSV) vaccine candidate showed an overall vaccine efficacy of 82.6% against RSV lower respiratory tract disease (RSV-LRTD) in adults aged 60 years and above, meeting the main goal of a phase 3 trial. The British pharma giant reported more data from the late-stage … Read more
Hutchmed begins dosing in phase 2/3 trial of sovleplenib for red blood cell disorder Source link
The European Central Bank (ECB) Eurosystem digital euro project’s two-year investigative phase has reached its halfway point. The ECB published a progress report Sept. 29 that looked at design and policy issues that are under consideration or have been decided. The report said commerce in physical stores and online is the biggest use case for … Read more
At the Converge22 conference in San Francisco, Jeremy Allaire, CEO of stablecoin issuer Circle, said that the world is finally moving from the speculative value phase of crypto to the utility phase. Drawing parallels to the early days of the internet, he said: “It is an architecture that the internet was founded on many decades … Read more
Odyssey Health rises 11% on completing phase 1 trial of concussion treatment Source link
The timeline had been set during former British Prime Minister Boris Johnson’s visit to India in April The timeline had been set during former British Prime Minister Boris Johnson’s visit to India in April The free trade agreement (FTA) talks between India and the UK are now in their final phase and despite some outstanding … Read more
FDA puts partial clinical hold on a DBT Technologies peanut allergy patch phase 3 trial Source link
The US Senate voted on Wednesday to approve an international climate treaty that would phase out the use of potent greenhouse gases used in refrigerators and air conditioners. By a vote of 69 to 27, the Senate agreed that the US should join the 2016 Kigali Amendment, alongside 137 other countries, and pledge to reduce … Read more
ATOM struggles to break $17 as the price gets rejected. The price of ATOM enters the distribution phase on a daily timeframe. ATOM’s price needs to hold the key support at $12 to maintain a bullish structure. Hidden bearish divergence resurfaces in the 4H timeframe. Cosmos (ATOM) has been the major player of the current … Read more
Nick Wright predicted the Los Angeles Rams would defeat Josh Allen’s Buffalo Bills in the NFL kickoff game. Nick reacts to the Bills 31-10 win and explains what this means for Matthew Stafford and the Super Bowl Champs. 5 MINUTES AGO・First Things First・3:07 Source link